Researchers investigate the potential dysregulation of tumor necrosis factor receptor-associated factor 2 (TRAF2) and its biological function in liver cancer, and elucidate the underlying mechanism, leading to the validation of TRAF2 as an attractive liver cancer target.
[Cell Death & Differentiation]